Back to News
Market Impact: 0.2
Cantor Fitzgerald Initiates Coverage of Sol-Gel Technologies at Overweight
Source: Nasdaq
Analyst InsightsHealthcare & Biotech
Cantor Fitzgerald initiated coverage of Sol-Gel Technologies on October 14, 2026, with an Overweight recommendation. The article identifies Sol-Gel as an Israel-based pharmaceutical company focused on dermatology and developing proprietary branded products; it provides no price target or market reaction.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
Ticker Sentiment
SLGL0.45
More News
- Dell stock plunges 11%, leading data center sell-off on concerns about 'enterprise AI timing'
- AI infrastructure stocks tumble. Here's a few reasons for the sell-off
- Merck CEO tells CNBC he expects breakthrough cancer vaccine will become faster to make
- A second major Wall Street bank this week is telling clients to cash in tech stocks. Here's why
- Why Dell’s stock was one of the S&P 500’s biggest laggards on Wednesday
- These stocks offer some of the best risk-adjusted upside on Wall Street
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- How to Search Earnings Call Transcripts With AI
- What a Concept From Nature Tells Us About How C-Suite Executives Actually Think About AI